Mayne Pharma | MYX - Selling And Administration Expenses

Stock Price
2.63
Daily Change
0.06 2.33%
Monthly
11.91%
Yearly
-62.43%
Q2 Forecast
2.52

Mayne Pharma reported AUD54.8M in Selling and Administration Expenses for its fiscal semester ending in June of 2024.





Selling And Administration Expenses Change Date
Ansell USD 274.8M 7.6M Dec/2025
Avita Medical AUD 19.03M 1.95M Dec/2025
Cochlear AUD 449.4M 214.45M Dec/2025
CSL USD 1.23B 498M Dec/2025
Healius AUD 393.4M 378.35M Dec/2024
Integral Diagnostics AUD 169.98M 18.73M Jun/2024
Medical Developments International AUD 2.84M 4.19M Dec/2025
Nanosonics AUD 53.78M 26.93M Dec/2025
Polynovo AUD 17.04M 1.91M Dec/2025
Ramsay Health Care AUD 5.29B 3.2M Dec/2024
ResMed USD 275.7M 16.51M Dec/2025
Sigma Healthcare AUD 134.77M 9.73M Dec/2024
Sonic Healthcare AUD 2.52B 2.46B Dec/2024
Telix Pharmaceuticals AUD 93.48M 1.04M Dec/2025